about
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assayUnderstanding and Managing Pregnancy in Patients with Lupus"New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndromeCardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE.Recent advances in understanding antiphospholipid syndrome.Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop?Top 10 clinical research developments in antiphospholipid syndrome.Management of recurrent thrombosis in antiphospholipid syndrome.Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome.Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation.The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores.Current status and future prospects for the treatment of antiphospholipid syndrome.Independent validation of the adjusted GAPSS. Role of thrombotic risk assessment in the real-life setting.Anti-phospholipid Antibodies and Smoking: An Overview.Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome.The Laboratory Diagnosis of the Antiphospholipid Syndrome.Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers.Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study.Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.The global anti-phospholipid syndrome score in primary APS.The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study.Impact of Classical Risk Factors for Arterial or Venous Thrombosis in Patients With Antiphospholipid Syndrome.Diagnosis and management of the antiphospholipid syndrome.Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome.Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis.Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
P2860
Q26739950-CE6E38CA-9E0F-41B8-8B19-6180E2C3E0B3Q26798179-98240C25-ADEA-4B17-9575-332568B82D93Q35250419-1EE2A7FD-727D-4C62-ABA5-4455F65231E8Q36303250-91801293-7E1D-4C7D-A9F6-A459EDE83E9CQ37063656-BC08384F-CC1D-4FF5-A14D-AD3590DD6AF3Q37577693-991270B3-E787-4FBB-B5ED-FA30B6606A6FQ38089684-59F35E31-C579-402D-8FCA-1A332335D2F6Q38135335-4DBF6376-B0A5-4A80-A75E-65046CEB411AQ38180647-20713BC2-7F46-47C9-AD20-C65511BB7360Q38250310-B0857FA7-E14D-4091-A927-C39E41D982D7Q38250311-A8AB2F4E-1BB5-416D-AD54-0861AE04C972Q38570944-15E58948-8B4D-470E-93BC-55BE4F228F7CQ38657043-C1ADDBB9-F18E-4491-86AA-7C9005F36CECQ38663014-767A6994-519C-4218-A4AA-07768069126DQ38818425-20B58F45-F8D0-49BA-8858-D00343DFAFC3Q38848271-E529461A-3830-40DF-8A07-90120C6FFCA1Q38885685-14501ABD-9053-4228-A364-8083AC5DE60EQ39065301-D7A38831-992A-42F9-9378-024B1DF45C62Q39134202-2D3E8BB4-3E87-4568-BD62-2A6644E8E79BQ41200243-47894D3E-C4B1-4CAD-BC51-0AA402F16EE5Q41595596-7C4C1005-6EFE-4D6B-8DF4-40F04742A399Q41619784-22022730-671D-4F75-9C79-8E1C14998ED0Q45130401-16DF6491-E44D-48FB-90BC-8EBEACA5967AQ45873735-F5B12BD2-3A1A-4E21-93B5-CA9806C19151Q47705471-A11F9518-E746-40D8-8663-6D8ED645816DQ47982275-30447662-8886-4D69-8334-BB9EBBAFC241Q47998109-6DA68490-4B0E-4A14-BDEE-33D3BB61AC92Q48005192-7F125554-B25A-45C6-9071-B0649A8EF289Q48533935-A4D2AF8C-AFE0-493A-88DA-BEDBC6E8C098Q50737245-1AE08CD3-3580-4504-B89D-02DB8EE4D8CCQ52597638-1F645F1A-28ED-486A-AE5A-4030FB116E8C
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
GAPSS: the Global Anti-Phospholipid Syndrome Score.
@en
GAPSS: the Global Anti-Phospholipid Syndrome Score.
@nl
type
label
GAPSS: the Global Anti-Phospholipid Syndrome Score.
@en
GAPSS: the Global Anti-Phospholipid Syndrome Score.
@nl
prefLabel
GAPSS: the Global Anti-Phospholipid Syndrome Score.
@en
GAPSS: the Global Anti-Phospholipid Syndrome Score.
@nl
P2093
P2860
P356
P1433
P1476
GAPSS: the Global Anti-Phospholipid Syndrome Score.
@en
P2093
Dario Roccatello
Giovanni Sanna
Maria Laura Bertolaccini
Savino Sciascia
Veronica Murru
P2860
P304
P356
10.1093/RHEUMATOLOGY/KES388
P577
2013-01-12T00:00:00Z